Sep 2026 · Announcement under Regulation 30 (LODR)-Press Release / Media Release 30 Sep - ASMS and Huwel Lifesciences expand RT-PCR commercialization platform across India on 30 September 2026.
Source: Bse
IT stocks · Small cap · NSE
Avio Smart Market Stack Limited (ASMS) is a diversified platform company focused on building scalable businesses across three divisions: Financial Inclusion & Digital Services, Agri Supply Chain & Technologies, and Diagnostics & Healthcare.
full bear SMA stack · SMA20 -12.7% / mo · MACD + · near 52W low · sector +14.5pp vs Nifty 500 (3M)
Latest mapped FPI equity flow was not positive. View sector evidence
Adjusted completed-session prices, rebased to 100
Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend is neutral, and recent execution is weak.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Revenue +34.3% · PAT -1.1% YoY
Price trend and sector-relative-strength timing.
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Financial-only signal; management claim evidence is not sufficient yet.
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
PAT -1% YoY · Rev +34% YoY · margin expansion
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹12 Cr | +34.3% | -65.2% |
| EBITDA | ₹0.1 Cr | +115.9% | -94.4% |
| Operating margin | 1.1% | +1038 bps | -566 bps |
| PAT | ₹0.9 Cr | -1.1% | -55.8% |
| PAT margin | 7.7% | +259 bps | +164 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Updated 20/10/2026
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Signals are conflicting — long-term trend down. RSI 30. Wait for confirmation.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
U-Score 40 · legacy U-Score band WATCHLIST · valuation evidence and comparable companies
Top U-Score contributors and drags from the latest stored fundamentals.
For this sector, IndiaPulse uses a blended lens rather than relying on a single valuation ratio.
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
12 stored score snapshots. Latest stored move: +0 points.
Business-comparable peers in IT — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Growth engines, risks, management commitments and evidence-backed delivery
FY26 revenue surged 160% YoY to ₹103.96 Cr, with PAT increasing 240% YoY to ₹5.94 Cr. Reserves turned positive to ₹3.72 Cr, driven by strong growth in the new Agri Supply Chain & Technologies vertical.
The company's strategic diversification into Agri Supply Chain & Technologies has significantly accelerated growth, making it the largest revenue contributor in FY26. While Financial Inclusion shows continued expansion, the Diagnostics & Healthcare segment is an early-stage strategic investment.
Latest issuer-disclosed distribution across 3 reported categories.
Emerged as the largest business vertical, contributing 58% of FY26 revenue, driven by Project Avio launch in Dec 2025.
Diagnostics & Healthcare represents the Company's largest strategic investment platform, with a partnership with Huwel Lifesciences.
MoUs executed across agri retail, warehousing, rural finance, mechanization, bio-inputs, and carbon credits.
Agritech application soft-launched with full-scale rollout planned.
Target to open 1,000 smart agri-stores for agri-input retail and agri-output aggregation over the next three years.
Changes in government policies and regulations are a potential risk.
Domestic and global economic conditions may impact performance.
Competition in operating markets is a factor.
Business risks associated with operating in rural and frontier markets.
Access to funding for operations and expansion is a potential risk.
Potential supply chain disruptions could affect operations.
Cybersecurity threats are a stated risk.
Need for regulatory approvals for various initiatives.
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
Annual financial results are presented with explicit year-on-year comparisons, indicating significant growth from a smaller base across key metrics like revenue and PAT.
Operates in 5,000 villages.
Access to a combined rural population of ~40 Million.
Partners with 7 Public & Regional Rural Banks across 10 states.
Huwel Lifesciences, a strategic partner, has 140+ molecular diagnostic products.
Intends to facilitate transactions with a GMV of USD 1 Billion through rural commerce, agri-inputs, and market access over three years.
Aims to digitally onboard 20 million farmers out of the 40 million currently serviced over the next three years.
Strategically partnered with Huwel Lifesciences to build a scalable molecular diagnostics platform, supporting R&D and market expansion.
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| Agri-tech GMV | Not yet disclosed | Progress towards USD 1 Billion GMV target over three years. |
| Smart Agri-stores | 0 (as of Dec 2025 launch) | Progress towards 1,000 smart agri-stores over three years. |
| Farmers Digitally Onboarded | Not yet disclosed | Progress towards onboarding 20 million farmers over three years. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 72nd percentile of the scored universe and 71st percentile within IT. Main check: results consistency is weak at 50/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
overall median 67 · IT: 71st pctile, median 69 · Small: 75th pctile, median 66
17 documents have extracted text, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Latest exchange and company disclosures found within the past two years.
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse